©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 110331
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110331
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110331
Table 2 Clinical and laboratory data of participants with liver cirrhosis (n = 20)
| Variable | Data |
| Etiology | |
| Alcohol | 8 |
| Autoimmune hepatitis | 1 |
| Hepatitis C | 5 |
| Drug-induced | 4 |
| NASH | 2 |
| MELD | 11 ± 3 |
| CTP | |
| A | 19 |
| B | 1 |
| Signs1 | |
| Ascites | 2 |
| Esophageal varices | 4 |
| Fatigue | 6 |
| Palmar erythema | 1 |
| Jaundice | 2 |
| Laboratory data | |
| Albumin (g/dL) | 3.62 ± 0.55 |
| Total bilirubin (mg/dL) | 1.01 ± 0.50 |
| Indirect bilirubin (mg/dL) | 0.44 ± 0.16 |
| INR | 1.23 ± 0.25 |
| GGT (U/L) | 186.67 ± 274.75 |
| AST/SGOT (U/L) | 44.79 ± 32.75 |
| ALT/SGPT (U/L) | 31.32 ± 19.01 |
| Creatinine (mg/dL) | 1.28 ± 1.48 |
- Citation: Corrêa FCCR, Nader ISTP, Riolino MRS, Silva E. Intra-rater reliability of the 6-min walk test in people with liver cirrhosis. World J Hepatol 2025; 17(11): 110331
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/110331.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.110331